FDA Import Refusal 1FX-2603810-9/10002/3 — Intas Pharmaceuticals Limited
The FDA refused shipment 1FX-2603810-9/10002/3 from Intas Pharmaceuticals Limited (India) on Jul 14, 2026. The refused product falls under Drugs and Biologics — FLUNARIZINE HCL (VASODILATOR). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jul 14, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 66SCY05 FLUNARIZINE HCL (VASODILATOR)
- Charges
- 75